This is a demo store. No orders will be fulfilled.
Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
12 Aug 2014  |  Asia Pacific
Malaysia Healthcare Outlook
Showcasing Value Propositions for Investors
The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores oppor...
$3,950.00 -
07 Aug 2014  |  Asia Pacific
China Wound Care Market
Is the Local Potential Much Higher than the Exports?
The Chinese wound care market is in the growth stage. Growing ageing population and rise in the incidence of lifestyle diseases, coupled with the increase in risk of chronic wounds and in affordability of better quality of wound care products provide the impetus for the Chinese wound care market. Universal coverage of public health insurance scheme...
$3,950.00 -
24 Jul 2014  |  Asia Pacific
Emerging Pharma Trends that will Revolutionize the Healthcare Landscape in the Asia Pacific
This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.
$500.00 -
03 Jul 2014  |  Asia Pacific
2014 Asia-Pacific Medical Devices Outlook
Changing Demographics and Landscape Set Stage for the Future
Medical devices plays a key role in a vibrant healthcare industry. An increasing aging population with increasing communicable and non-communicale diseases and most governments providing subisidized healthcare translate the need for cost-effective medical devices. Governments need to meet these expectations by policy librealization and revamping re...
$3,950.00 -
28 May 2014  |  Asia Pacific
Profiling of Top 50 Healthcare Service Providers in Asia-Pacific
A Deep-dive Analysis of the Business and Financial Health of Leading Companies in the Region
Increased competition between healthcare providers which has lead to increased development of competitive features, such as premium care facilities, aesthetic and wellness medicine facilities, improved patient customer service, and so on. This has also stimulated the increased application of technology in both medical devices and information and c...
$4,950.00 -
26 May 2014  |  Asia Pacific
Indonesian Infectious Disease IVD Market
Mapping the Market for Investment, Best Practices, and Growth Potential
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...
$4,950.00 -
23 May 2014  |  Asia Pacific
Western European Companion Diagnostics Market
Regulatory Hurdles and LDTs Stall the Global and European Market for Companion Diagnostics
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...
$4,950.00 -
20 May 2014  |  Asia Pacific
Russia In Vitro Diagnostics (IVD) Market Data
Early Detection Provides New Opportunities for IVD Industry
This study provides data for the Russian in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, immunochemistry, and others namely, tissue diagnostics and self-monitoring blood glucose, are the segments discussed in this market. Market reve...
$3,950.00 -
05 May 2014  |  Asia Pacific
Russia Hematology Diagnostics Market Data
Russian Governments Support for Development of In Vitro Diagnostic Industry Propels Adoption of High End Analyzers
This study provides market data for the Russian hematology diagnostics market. Segments in the market include instruments and reagents. Instruments are further segmented by 5PD and 3PD analyzers. Market revenues, installed base units, and market share are included in this deliverable. Further analysis is provided in a separate deliverable to accomp...
$3,950.00 -
05 May 2014  |  Asia Pacific
Russia Urinalysis Market Data
Increase in Test Volume Creates a Favorable Market for Reagents
This study provides market data for the Russian urinalysis market. Market segments include sediment, dipstick, and integrated systems. Sediment and dipstick segments are further segmented by instruments and reagents. Integrated systems is further segmented by instruments. In this deliverable, market revenues, installed base units, and market share ...
$3,950.00